PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108. A total of 166 filers reported holding PORTOLA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 3.71 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $17,316,000 | +120.5% | 962,548 | -12.6% | 0.00% | +100.0% |
| Q1 2020 | $7,854,000 | -66.3% | 1,101,570 | +13.0% | 0.00% | -60.0% |
| Q4 2019 | $23,281,000 | -10.3% | 974,865 | +0.8% | 0.01% | -16.7% |
| Q3 2019 | $25,950,000 | +13.6% | 967,539 | +14.9% | 0.01% | +20.0% |
| Q2 2019 | $22,844,000 | -20.8% | 842,030 | +1.3% | 0.01% | -28.6% |
| Q1 2019 | $28,831,000 | +83.7% | 830,822 | +3.4% | 0.01% | +75.0% |
| Q4 2018 | $15,692,000 | -28.6% | 803,879 | -2.6% | 0.00% | -20.0% |
| Q3 2018 | $21,980,000 | -29.0% | 825,384 | +0.7% | 0.01% | -37.5% |
| Q2 2018 | $30,955,000 | +28.4% | 819,568 | +11.1% | 0.01% | +33.3% |
| Q1 2018 | $24,101,000 | -32.6% | 737,950 | +0.5% | 0.01% | -33.3% |
| Q4 2017 | $35,734,000 | -3.9% | 734,070 | +6.7% | 0.01% | -10.0% |
| Q3 2017 | $37,173,000 | +4.1% | 687,985 | +8.2% | 0.01% | 0.0% |
| Q2 2017 | $35,724,000 | +47.9% | 635,998 | +3.2% | 0.01% | +42.9% |
| Q1 2017 | $24,152,000 | +78.7% | 616,279 | +2.3% | 0.01% | +75.0% |
| Q4 2016 | $13,517,000 | -0.2% | 602,341 | +1.0% | 0.00% | 0.0% |
| Q3 2016 | $13,550,000 | -4.4% | 596,622 | -0.7% | 0.00% | -20.0% |
| Q2 2016 | $14,179,000 | +12.2% | 600,833 | -0.5% | 0.01% | +25.0% |
| Q1 2016 | $12,634,000 | -59.1% | 603,600 | +0.5% | 0.00% | -60.0% |
| Q4 2015 | $30,916,000 | +33.1% | 600,886 | +10.2% | 0.01% | +25.0% |
| Q3 2015 | $23,233,000 | -0.1% | 545,140 | +6.8% | 0.01% | +14.3% |
| Q2 2015 | $23,261,000 | +20.5% | 510,658 | +0.4% | 0.01% | +16.7% |
| Q1 2015 | $19,311,000 | +38.4% | 508,719 | +3.3% | 0.01% | +50.0% |
| Q4 2014 | $13,952,000 | +25.3% | 492,659 | +11.9% | 0.00% | +33.3% |
| Q3 2014 | $11,134,000 | +131.1% | 440,434 | +166.8% | 0.00% | +50.0% |
| Q2 2014 | $4,817,000 | +5.2% | 165,086 | -6.6% | 0.00% | +100.0% |
| Q1 2014 | $4,579,000 | +23.3% | 176,784 | +22.5% | 0.00% | 0.0% |
| Q4 2013 | $3,715,000 | +10.0% | 144,258 | +14.3% | 0.00% | 0.0% |
| Q3 2013 | $3,376,000 | +162.7% | 126,201 | +141.5% | 0.00% | – |
| Q2 2013 | $1,285,000 | – | 52,260 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 1,220,672 | $55,602,000 | 9.30% |
| Fernwood Investment Management, LLC | 201,211 | $9,165,000 | 7.20% |
| Cormorant Asset Management, LP | 500,000 | $22,775,000 | 3.03% |
| Ghost Tree Capital, LLC | 170,000 | $7,744,000 | 2.51% |
| HARVEY CAPITAL MANAGEMENT INC | 155,030 | $7,108,000 | 2.40% |
| SECTORAL ASSET MANAGEMENT INC | 1,169,130 | $53,254,000 | 2.22% |
| Atika Capital Management LLC | 98,000 | $4,464,000 | 2.01% |
| Temasek Holdings (Private) Ltd | 5,833,568 | $265,719,000 | 1.66% |
| CABOT WEALTH MANAGEMENT INC | 124,309 | $5,662,000 | 1.38% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 314,689 | $14,334,000 | 1.11% |